For Individuals and Businesses
A Partnership Created for Community
Bear River Health Primary Care (BRHPC), in an effort to support the community during the COVID-19 crisis, will be providing Serological and Polymerase Chain Reaction (PCR) testing for the public in Charlevoix, Emmet and Otsego counties. As infection rates of the SARS-Co-2 virus (COVID-19) increased around the world, Bear River Health (BRH) in conjunction with BRHPC put in place certain measures to ensure continuity of services to the substance use disorder community of which it serves. While Northern Michigan as a whole has been impacted less than more populous areas in the country and state, rates of infection continue to rise. Success in maintaining a COVID-19 free campus, which includes over 200 clients and staff members, is something about which BRHPC is very proud. In hopes of giving back to the community that has given so much, BRHPC is reaching out to share the success with you. If a business is interested in clearance testing employees before reopening, contact Jason Sweeney at email@example.com.
COVID-19 Testing Sites
Tuesday June 2, 2020 at BRH Primary Care 2329 Center Street in Boyne Falls from 10am-2pm
Wednesday June 3, 2020 at Hayes Township Hall 9195 Old US 31 Hwy N, Charlevoix 3pm-7pm
Tuesday June 9, 2020 at BRH Primary Care 2329 Center Street in Boyne Falls from 3pm-7pm
Wednesday June 10, 2020 at Hayes Township Hall 9195 Old US 31 Hwy N, Charlevoix 10am-2pm
Tuesday June 16, 2020 at BRH Primary Care 2329 Center Street in Boyne Falls from 10am-2pm
Wednesday June 17, 2020 at Hayes Township Hall 9195 Old US 31 Hwy N, Charlevoix 3pm-7pm
Serological tests use a participant’s blood, serum, or plasma to identify the presence of antibodies. This allows a determination of active infection and whether someone has built up an immunity to the virus based on past exposure. Serological tests detect antibodies present in the blood when the body is responding to a specific infection, like COVID-19. They detect the body’s immune response to the infection caused by the virus rather than detecting the virus itself. In the early days of an infection, when the body’s immune response is still building, antibodies may not be present in detectable levels. This limits the test’s effectiveness for diagnosing COVID-19 and is why it should not be used as the sole basis for diagnosis. Currently, authorized serological tests for COVID-19 measure IgM and/or IgG antibodies. Since IgM antibodies may not develop early, or at all, in infected participants this type of antibody test is not used to rule out COVID-19. Since IgG antibodies generally do not develop until later, this type of antibody test, even though it is more specific to COVID-19, is not used to rule-out the infection in an individual. Typically, IgM peaks at day 5 and lgG peaks at 14-21 days. IgM appears first and then slowly drops off. As IgM disappears and IgG picks up, this indicates the participant is likely entering recovery and at some point no longer contagious. The test is easy to administer, offering reliable results in 10 minutes.
Polymerase Chain Reaction Testing
Polymerase Chain Reaction Testing (PCR) is a laboratory test to diagnose COVID-19 infection based on viral DNA. The test involves a nasopharyngeal swab that looks like a long Q-tip and draws mucus from the back of the participant’s nasal cavity where it meets the throat. The swab is then inserted into a vial and is shipped to a laboratory where lab techs or machines use reagents to extract the viral RNA. An enzyme, Reverse Transcriptase, is used to convert the RNA into DNA and the DNA is replicated many times to make it detectable. PCR tests are able to identify the virus before the antibody test. Serology tests are not very effective at identifying infection in the pre-symptomatic or early symptomatic stages. PCR begins to lose sensitivity by 3-6 days. However, IgM serology starts becoming very sensitive and showing positives at 5 days. This means, there are situations in which a participant comes in for testing around this time and a PCR based test could be negative, but IgM could be positive. There is a period of time where IgM becomes more sensitive than PCR. The PCR test usually takes 48-72 hours for results to become available.
It has been determined that the best and most effective way to test for COVID-19 is to administer both the serological and PCR tests. BRHPC testing staff will first administer the Serology test. The serology test involves getting a sample of the participant’s blood by pricking the finger. The blood is then placed onto a cassette and a buffer added. Results become available in 10 minutes. The participant’s results determine whether isolation and follow-up procedures are necessary. As discussed above, the serological test should be used in tandem with the PCR test, which BRHPC will also administer. The PCR test involves collecting a specimen through a nasopharyngeal swab and sending the specimen to the lab to be processed. The isolation and follow-up measures depend on the results of the two tests as follows:
- If the participant is symptomatic at the time of testing, they should be quarantined and a follow-up appointment scheduled with BRHPC to administer the tests in an environment where a higher level of infection control can be utilized.
- If the participant is asymptomatic and neither IgM or IgG is detected, then the participant is presumed negative and free of COVID-19. No isolation measures need be taken pending results of the PCR test.
- If the participant is asymptomatic, and the serological test indicates the presence of IgM alone, then the participant must take isolation measures pending results of the PCR test.
- If the participant is asymptomatic and the test indicates the presence of IgG alone, the participant is considered to be in the late stages of recovery and not contagious. No isolation measures need be taken pending results of the PCR test.
- If the participant is asymptomatic, but the serological test indicates the presence of both IgM and IgG, then the participant is considered to be in the early stages of recovery and must take isolation measures pending results of the PCR test.
Isolation Measures Following Positive Serology Test
Isolation measures should be taken when the test results indicate such measures are necessary. The participant should be isolated from the general population until a negative result from the PCR test is received, or 10 days after symptoms dissipate. These measures should include quarantine in a room separated from the general population. Center for Disease Control and Prevention (CDC) quarantine rules permit the housing of multiple COVID-19 positive persons in an isolation area, though suspected cases should be held separate from confirmed. Access to the participant should be limited to as few people as necessary to meet their basic needs and monitor for symptoms. The participant should be masked to avoid shedding of the virus. All persons with access to the participant should maintain the six foot requirement for social distancing and wear the proper personal protection equipment (PPE), including gloves and masks. The isolation room should be regularly disinfected.
Upon release from isolation the participant’s clothing and bedding should be handled carefully with the proper PPE and washed separately from general laundry. The isolation room and any other items the participant had access to should then be sanitized.
Notice, Follow-up Testing, Aftercare
BRHPC will notify you of your results. Any participant testing positive will be notified directly by BRHPC. If a participant tests positive for IgM alone, both IgM and IgG, or a positive result from the PRC test, BRHPC will provide a consultation on the quarantine measures described above. Any positive results will be relayed to the local Health Department for tracing and tracing purposes. BRHPC also offers aftercare, including managing symptoms, medicine and follow-up testing. All of the services are offered at no out of pocket cost to you. BRHPC can bill your insurance for all costs involved. For those without insurance, BRHPC is able to bill through a federally funded program providing reimbursement for testing, follow-up and aftercare to uninsured persons. Any positive results will be relayed to the local health department for tracing and tracking purposes.